000			01839 a2200529 4500
005			20250513230333.0
264		0	_c20010524
008			200105s 0 0 eng d
022			_a0007-1188
024	7		_a10.1038/sj.bjp.0703834 _2doi
040			_aNLM _beng _cNLM
100	1		_aWiley, K E
245	0	0	_aNitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. _h[electronic resource]
260			_bBritish journal of pharmacology _cJan 2001
300			_a213-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAorta, Thoracic _xdrug effects
650	0	4	_aCyclic GMP _xmetabolism
650	0	4	_aEndothelin Receptor Antagonists
650	0	4	_aEndothelin-1 _xmetabolism
650	0	4	_aFemale
650	0	4	_aGuanylate Cyclase _xantagonists & inhibitors
650	0	4	_aHeart Ventricles _xdrug effects
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aMammary Arteries _xdrug effects
650	0	4	_aMass Spectrometry
650	0	4	_aMiddle Aged
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aNitric Oxide Donors _xpharmacology
650	0	4	_aRadioligand Assay
650	0	4	_aReceptors, Endothelin _xmetabolism
650	0	4	_aSignal Transduction _xphysiology
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVentricular Function
700	1		_aDavenport, A P
773	0		_tBritish journal of pharmacology _gvol. 132 _gno. 1 _gp. 213-20
856	4	0	_uhttps://doi.org/10.1038/sj.bjp.0703834 _zAvailable from publisher's website
999			_c11096235 _d11096235